PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-175.33%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would suspect a firm-specific problem if peers maintain profit growth.
58.54%
D&A growth of 58.54% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
-604.67%
Deferred tax shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see potential advantage if actual tax outflows do not spike.
116.21%
SBC growth of 116.21% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or staff additions causing more equity grants.
-110.50%
Working capital is shrinking yoy while Healthcare median is -40.43%. Seth Klarman would see an advantage if sales remain robust.
-42.57%
AR shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage in working capital if sales do not drop.
124.76%
Inventory growth of 124.76% while Healthcare median is zero at 0.00%. Walter Schloss would question if expansions or new product lines require extra stock.
-164.55%
AP shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see better immediate cost coverage if top-line remains intact.
70.64%
Some yoy usage while Healthcare median is negative at -23.89%. Peter Lynch would see peers cutting these lines more aggressively or not needing them.
-51.87%
Other non-cash items dropping yoy while Healthcare median is -4.74%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
-1622.35%
Negative CFO growth while Healthcare median is -13.70%. Seth Klarman would suspect a firm-specific operational weakness if peers maintain growth.
-178.71%
CapEx declines yoy while Healthcare median is 0.00%. Seth Klarman would note a short-term FCF advantage if revenue is stable.
-100.00%
Acquisition spending declines yoy while Healthcare median is 0.00%. Seth Klarman would note reduced M&A risk if growth continues organically.
-100.00%
Investment purchases shrink yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term cash advantage if no high-return opportunities are missed.
-100.00%
We liquidate less yoy while Healthcare median is 0.00%. Seth Klarman would see a firm-specific hold strategy unless missed gains exist.
336.42%
Growth of 336.42% while Healthcare median is zero at 0.00%. Walter Schloss questions intangible or special projects explaining that difference.
-102.53%
Reduced investing yoy while Healthcare median is 0.00%. Seth Klarman sees potential advantage in near-term liquidity if revenue remains stable.
85.58%
Debt repayment growth of 85.58% while Healthcare median is zero at 0.00%. Walter Schloss wonders if expansions or a shift in capital structure drive that difference.
-100.00%
We reduce issuance yoy while Healthcare median is 0.00%. Seth Klarman might see an advantage in preserving per-share value unless expansions are neglected.
No Data
No Data available this quarter, please select a different quarter.